Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2012; 18(47): 7070-7078
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.7070
Table 1 Expression levels of transforming growth factor β1 or connective tissue growth factor mRNA in human hepatocellular carcinoma (mean ± SD)
nTGF-β1 mRNA (A)CCN2 mRNA (A)
Normal control66.24 ± 2.356.42 ± 2.35
Carcinoma foci3615.02 ± 4.43b12.36 ± 6.08b
Stroma around carcinoma foci3647.56 ± 7.31d60.27 ± 28.71d
Table 2 Effect of connective tissue growth factor on HepG2 cell cycle progression
GroupsG0-G1SG2-M
Normal control53.56 ± 2.5110.94 ± 0.2334.17 ± 1.29
CCN241.01 ± 4.45a23.85 ± 2.35a34.17 ± 1.29
TGF-β154.97 ± 1.8812.07 ± 2.4433.30 ± 0.73